Can a gel ease menopause symptoms that disrupt daily life?

NCT ID NCT07737782

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study examines the most common symptoms of genitourinary syndrome of menopause (GSM) in postmenopausal women and how these symptoms impact quality of life. Researchers will also look at whether using a non-hormonal topical gel called XCM INTIM for at least 8 weeks is linked to changes in symptom severity and quality-of-life measures. The study uses medical records and patient questionnaires to gather data.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a non-hormonal topical vulvovaginal gel called XCM INTIM
What this could lead to
If the data suggest improvement, it could support the use of this gel for easing GSM symptoms and improving quality of life.
What could go wrong
This is a small, retrospective study that looks back at existing records, so it cannot prove cause and effect. Results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSPAREUNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario La Luz Quirónsalud

    Madrid, Madrid, 28003, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.